カテゴリー： GlobalInfoResearch, 世界

高血圧薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Antihypertensive Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101665）・商品コード：GIR9101665
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月12日（※2024年版があります。お問い合わせください）
・ページ数：121
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、高血圧薬の世界市場について調べ、まとめました。種類別セグメントは、利尿降圧薬、交感神経抑制薬、レニン-アンジオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬等、用途別セグメントは、老人、妊婦、一般患者等に区分しました。高血圧薬の世界市場概観、メーカー動向、メーカー別高血圧薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・高血圧薬の市場概観
・高血圧薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・高血圧薬の企業別販売動向、市場シェア、市場集中度、競争動向
・高血圧薬の世界市場規模
・高血圧薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・高血圧薬のアメリカ市場規模推移
・高血圧薬のカナダ市場規模推移
・高血圧薬のメキシコ市場規模推移
・高血圧薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・高血圧薬のドイツ市場規模推移
・高血圧薬のイギリス市場規模推移
・高血圧薬のロシア市場規模推移
・高血圧薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・高血圧薬の日本市場規模推移
・高血圧薬の中国市場規模推移
・高血圧薬の韓国市場規模推移
・高血圧薬のインド市場規模推移
・高血圧薬の東南アジア市場規模推移
・高血圧薬の南米市場分析（ブラジル、アルゼンチン等）
・高血圧薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・高血圧薬の種類別分析/販売量、売上、市場シェア（利尿降圧薬、交感神経抑制薬、レニン-アンジオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬）
・高血圧薬の用途別分析/市場規模（老人、妊婦、一般患者）
・高血圧薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・高血圧薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension.

Scope of the Report:
The worldwide market for Antihypertensive Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antihypertensive Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator

Market Segment by Applications, can be divided into
The Old
Pregnant Woman
General Patient

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antihypertensive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antihypertensive Drugs, with price, sales, revenue and global market share of Antihypertensive Drugs in 2017 and 2018.
Chapter 3, the Antihypertensive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antihypertensive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antihypertensive Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antihypertensive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Antihypertensive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Diuretic Antihypertensive
1.2.2 Sympathetic Suppressant
1.2.3 Renin-angiotensin System Inhibitor
1.2.4 Calcium Antagonist Medicine
1.2.5 vasodilator
1.3 Market Analysis by Applications
1.3.1 The Old
1.3.2 Pregnant Woman
1.3.3 General Patient
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Antihypertensive Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Antihypertensive Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Antihypertensive Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Antihypertensive Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Lupin
2.5.1 Business Overview
2.5.2 Antihypertensive Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lupin Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Ranbaxy Laboratories
2.6.1 Business Overview
2.6.2 Antihypertensive Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Antihypertensive Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Astra Zeneca
2.8.1 Business Overview
2.8.2 Antihypertensive Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astra Zeneca Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.2 Antihypertensive Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Takeda
2.10.1 Business Overview
2.10.2 Antihypertensive Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Takeda Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Actelion
2.11.1 Business Overview
2.11.2 Antihypertensive Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Actelion Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 United Therapeutics
2.12.1 Business Overview
2.12.2 Antihypertensive Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 United Therapeutics Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antihypertensive Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antihypertensive Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antihypertensive Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Antihypertensive Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antihypertensive Drugs Market Analysis by Regions
4.1 Global Antihypertensive Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antihypertensive Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Antihypertensive Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Antihypertensive Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antihypertensive Drugs Sales and Growth Rate (2014-2019)
4.5 South America Antihypertensive Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antihypertensive Drugs Sales and Growth Rate (2014-2019)
5 North America Antihypertensive Drugs by Country
5.1 North America Antihypertensive Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Antihypertensive Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Antihypertensive Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Antihypertensive Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Antihypertensive Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Antihypertensive Drugs Sales and Growth Rate (2014-2019)
6 Europe Antihypertensive Drugs by Country
6.1 Europe Antihypertensive Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Antihypertensive Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Antihypertensive Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Antihypertensive Drugs Sales and Growth Rate (2014-2019)
6.3 UK Antihypertensive Drugs Sales and Growth Rate (2014-2019)
6.4 France Antihypertensive Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Antihypertensive Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Antihypertensive Drugs by Country
7.1 Asia-Pacific Antihypertensive Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antihypertensive Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Antihypertensive Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Antihypertensive Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Antihypertensive Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Antihypertensive Drugs Sales and Growth Rate (2014-2019)
7.5 India Antihypertensive Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
8 South America Antihypertensive Drugs by Country
8.1 South America Antihypertensive Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Antihypertensive Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Antihypertensive Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antihypertensive Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Antihypertensive Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antihypertensive Drugs by Countries
9.1 Middle East and Africa Antihypertensive Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antihypertensive Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antihypertensive Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Antihypertensive Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Antihypertensive Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Antihypertensive Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Antihypertensive Drugs Sales and Growth Rate (2014-2019)
10 Global Antihypertensive Drugs Market Segment by Type
10.1 Global Antihypertensive Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Antihypertensive Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Antihypertensive Drugs Revenue and Market Share by Type (2014-2019)
10.2 Diuretic Antihypertensive Sales Growth and Price
10.2.1 Global Diuretic Antihypertensive Sales Growth (2014-2019)
10.2.2 Global Diuretic Antihypertensive Price (2014-2019)
10.3 Sympathetic Suppressant Sales Growth and Price
10.3.1 Global Sympathetic Suppressant Sales Growth (2014-2019)
10.3.2 Global Sympathetic Suppressant Price (2014-2019)
10.4 Renin-angiotensin System Inhibitor Sales Growth and Price
10.4.1 Global Renin-angiotensin System Inhibitor Sales Growth (2014-2019)
10.4.2 Global Renin-angiotensin System Inhibitor Price (2014-2019)
10.5 Calcium Antagonist Medicine Sales Growth and Price
10.5.1 Global Calcium Antagonist Medicine Sales Growth (2014-2019)
10.5.2 Global Calcium Antagonist Medicine Price (2014-2019)
10.6 vasodilator Sales Growth and Price
10.6.1 Global vasodilator Sales Growth (2014-2019)
10.6.2 Global vasodilator Price (2014-2019)
11 Global Antihypertensive Drugs Market Segment by Application
11.1 Global Antihypertensive Drugs Sales Market Share by Application (2014-2019)
11.2 The Old Sales Growth (2014-2019)
11.3 Pregnant Woman Sales Growth (2014-2019)
11.4 General Patient Sales Growth (2014-2019)
12 Antihypertensive Drugs Market Forecast (2019-2024)
12.1 Global Antihypertensive Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Antihypertensive Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Antihypertensive Drugs Market Forecast (2019-2024)
12.2.2 Europe Antihypertensive Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Antihypertensive Drugs Market Forecast (2019-2024)
12.2.4 South America Antihypertensive Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Antihypertensive Drugs Market Forecast (2019-2024)
12.3 Antihypertensive Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Antihypertensive Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Antihypertensive Drugs Market Share Forecast by Type (2019-2024)
12.4 Antihypertensive Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Antihypertensive Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Antihypertensive Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Antihypertensive Drugs Picture
Table Product Specifications of Antihypertensive Drugs
Figure Global Sales Market Share of Antihypertensive Drugs by Types in 2018
Table Antihypertensive Drugs Types for Major Manufacturers
Figure Diuretic Antihypertensive Picture
Figure Sympathetic Suppressant Picture
Figure Renin-angiotensin System Inhibitor Picture
Figure Calcium Antagonist Medicine Picture
Figure vasodilator Picture
Figure Antihypertensive Drugs Sales Market Share by Applications in 2018
Figure The Old Picture
Figure Pregnant Woman Picture
Figure General Patient Picture
Figure United States Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Antihypertensive Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Antihypertensive Drugs Type and Applications
Table Novartis Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antihypertensive Drugs Type and Applications
Table Pfizer Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Antihypertensive Drugs Type and Applications
Table Johnson & Johnson Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Antihypertensive Drugs Type and Applications
Table Sanofi Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Antihypertensive Drugs Type and Applications
Table Lupin Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ranbaxy Laboratories Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Laboratories Antihypertensive Drugs Type and Applications
Table Ranbaxy Laboratories Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antihypertensive Drugs Type and Applications
Table Merck Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Antihypertensive Drugs Type and Applications
Table Astra Zeneca Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Antihypertensive Drugs Type and Applications
Table Daiichi Sankyo Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Antihypertensive Drugs Type and Applications
Table Takeda Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Actelion Basic Information, Manufacturing Base and Competitors
Table Actelion Antihypertensive Drugs Type and Applications
Table Actelion Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table United Therapeutics Basic Information, Manufacturing Base and Competitors
Table United Therapeutics Antihypertensive Drugs Type and Applications
Table United Therapeutics Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Antihypertensive Drugs Sales by Manufacturer (2017-2018)
Figure Global Antihypertensive Drugs Sales Market Share by Manufacturer in 2017
Figure Global Antihypertensive Drugs Sales Market Share by Manufacturer in 2018
Table Global Antihypertensive Drugs Revenue by Manufacturer (2017-2018)
Figure Global Antihypertensive Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Antihypertensive Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Global Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table Global Antihypertensive Drugs Sales by Regions (2014-2019)
Table Global Antihypertensive Drugs Sales Market Share by Regions (2014-2019)
Table Global Antihypertensive Drugs Revenue by Regions (2014-2019)
Figure Global Antihypertensive Drugs Revenue Market Share by Regions in 2014
Figure Global Antihypertensive Drugs Revenue Market Share by Regions in 2018
Figure North America Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Europe Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure South America Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure North America Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table North America Antihypertensive Drugs Sales by Countries (2014-2019)
Table North America Antihypertensive Drugs Sales Market Share by Countries (2014-2019)
Figure North America Antihypertensive Drugs Sales Market Share by Countries in 2014
Figure North America Antihypertensive Drugs Sales Market Share by Countries in 2018
Table North America Antihypertensive Drugs Revenue by Countries (2014-2019)
Table North America Antihypertensive Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Antihypertensive Drugs Revenue Market Share by Countries in 2014
Figure North America Antihypertensive Drugs Revenue Market Share by Countries in 2018
Figure United States Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Canada Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Europe Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table Europe Antihypertensive Drugs Sales by Countries (2014-2019)
Table Europe Antihypertensive Drugs Sales Market Share by Countries (2014-2019)
Table Europe Antihypertensive Drugs Revenue by Countries (2014-2019)
Figure Europe Antihypertensive Drugs Revenue Market Share by Countries in 2017
Figure Europe Antihypertensive Drugs Revenue Market Share by Countries in 2018
Figure Germany Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure UK Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure France Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Russia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Italy Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Antihypertensive Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Antihypertensive Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Antihypertensive Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Antihypertensive Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Antihypertensive Drugs Revenue Market Share by Countries 2018
Figure China Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Japan Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Korea Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure India Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure South America Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table South America Antihypertensive Drugs Sales by Countries (2014-2019)
Table South America Antihypertensive Drugs Sales Market Share by Countries (2014-2019)
Figure South America Antihypertensive Drugs Sales Market Share by Countries in 2018
Table South America Antihypertensive Drugs Revenue by Countries (2014-2019)
Table South America Antihypertensive Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Antihypertensive Drugs Revenue Market Share by Countries in 2018
Figure Brazil Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antihypertensive Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Antihypertensive Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Antihypertensive Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Antihypertensive Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Antihypertensive Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Antihypertensive Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antihypertensive Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Antihypertensive Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure UAE Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Antihypertensive Drugs Sales and Growth Rate (2014-2019)
Table Global Antihypertensive Drugs Sales by Type (2014-2019)
Table Global Antihypertensive Drugs Sales Share by Type (2014-2019)
Table Global Antihypertensive Drugs Revenue by Type (2014-2019)
Table Global Antihypertensive Drugs Revenue Share by Type (2014-2019)
Figure Global Diuretic Antihypertensive Sales Growth (2014-2019)
Figure Global Diuretic Antihypertensive Price (2014-2019)
Figure Global Sympathetic Suppressant Sales Growth (2014-2019)
Figure Global Sympathetic Suppressant Price (2014-2019)
Figure Global Renin-angiotensin System Inhibitor Sales Growth (2014-2019)
Figure Global Renin-angiotensin System Inhibitor Price (2014-2019)
Figure Global Calcium Antagonist Medicine Sales Growth (2014-2019)
Figure Global Calcium Antagonist Medicine Price (2014-2019)
Figure Global vasodilator Sales Growth (2014-2019)
Figure Global vasodilator Price (2014-2019)
Table Global Antihypertensive Drugs Sales by Application (2014-2019)
Table Global Antihypertensive Drugs Sales Share by Application (2014-2019)
Figure Global Pregnant Woman Sales Growth (2014-2019)
Figure Global General Patient Sales Growth (2014-2019)
Figure Global Antihypertensive Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Antihypertensive Drugs Sales Forecast by Regions (2019-2024)
Table Global Antihypertensive Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Antihypertensive Drugs Market Forecast (2019-2024)
Figure Europe Sales Antihypertensive Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Antihypertensive Drugs Market Forecast (2019-2024)
Figure South America Sales Antihypertensive Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Antihypertensive Drugs Market Forecast (2019-2024)
Table Global Antihypertensive Drugs Sales Forecast by Type (2019-2024)
Table Global Antihypertensive Drugs Market Share Forecast by Type (2019-2024)
Table Global Antihypertensive Drugs Sales Forecast by Application (2019-2024)
Table Global Antihypertensive Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、Astra Zeneca、Daiichi Sankyo、Takeda、Actelion、United Therapeutics、

★調査レポート[高血圧薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101665)販売に関する免責事項を必ずご確認ください。
★調査レポート[高血圧薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 眼感染症薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101222 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、眼感染症薬の世界市場について調べ、まとめました。種類別セグメントは、レボフロキサシン、シプロフロキサシン、その他等、用途別セグメントは、結膜炎、麦粒腫、まぶたの感染、その他等に区分しました。眼感染症薬の世界市場概観、メーカー動向、メーカー別眼感染症薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・眼感染症薬の市場概観 ・眼感染症薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・眼感染症薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・眼感染症薬の世界市場規模 ・眼感染症薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・眼感染症薬のアメリカ市場規模推移 ・眼感染症薬のカナダ市場規模推移 ・眼感染症薬のメキシコ市場規模推移 ・眼感染症薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Eye Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Eye Infection Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Novartis Allergan Valeant Pharmaceuticals Santen Pharmaceutical Lupin Pharmaceuticals...
  • 処方整形外科薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101547 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方整形外科薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方整形外科薬の世界市場概観、メーカー動向、メーカー別処方整形外科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方整形外科薬の市場概観 ・処方整形外科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方整形外科薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方整形外科薬の世界市場規模 ・処方整形外科薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方整形外科薬のアメリカ市場規模推移 ・処方整形外科薬のカナダ市場規模推移 ・処方整形外科薬のメキシコ市場規模推移 ・処方整形外科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The prescription drugs are widely used for orthopedic surgery, which are used to treat arthritis, gout and others. Scope of the Report: The worldwide market for Prescription Orthopedic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Orthopedic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type...
  • 処方胃腸薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101548 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方胃腸薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方胃腸薬の世界市場概観、メーカー動向、メーカー別処方胃腸薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方胃腸薬の市場概観 ・処方胃腸薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方胃腸薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方胃腸薬の世界市場規模 ・処方胃腸薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方胃腸薬のアメリカ市場規模推移 ・処方胃腸薬のカナダ市場規模推移 ・処方胃腸薬のメキシコ市場規模推移 ・処方胃腸薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders. Scope of the Report: The worldwide market for Prescription Gastrointestinal Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Gastrointestinal Drugs in global market, especially in North America, Europe and Asia-Pacific,...
  • 精神療法薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101546 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、精神療法薬の世界市場について調べ、まとめました。種類別セグメントは、抗うつ薬、抗精神病薬、抗不安薬、ADHD薬、その他等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。精神療法薬の世界市場概観、メーカー動向、メーカー別精神療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・精神療法薬の市場概観 ・精神療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・精神療法薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・精神療法薬の世界市場規模 ・精神療法薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・精神療法薬のアメリカ市場規模推移 ・精神療法薬のカナダ市場規模推移 ・精神療法薬のメキシコ市場規模推移 ・精神療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A psychotherapeutics drug is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Scope of the Report: The worldwide market for Psychotherapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Psychotherapeutics Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on...

    • ◆H&Iグローバルリサーチのお客様（例）◆